| Name | Eyelash Growth Treatment - Latisse (Bimatoprost) |
| Uses | Enhancement of eyelash length, thickness, and darkness in patients with hypotrichosis (inadequate or sparse eyelashes). |
| Route Of Administration | Topical (applied to upper eyelid margin). |
| Frequency Of Use | Once daily at bedtime. |
| Concentration(s) | Bimatoprost ophthalmic solution 0.03%. |
| Maximum Dosage (Day, Wk) | One drop per upper eyelid margin per day; do not exceed recommended dose. |
| Contraindications | Active eye infections, history of glaucoma or intraocular pressure issues, hypersensitivity to bimatoprost or formulation excipients. |
| Possible Side Effects | Common: itching, eye redness, dryness, darkening of the eyelid skin. Rare: increased iris pigmentation, vision changes, allergic reaction. |
| Compatibility With Other Treatments/Drugs | Use caution with glaucoma medications, as bimatoprost may affect intraocular pressure. |
| Allergies | Assess for hypersensitivity to bimatoprost or inactive ingredients in the formulation. |
| Administration Time | Apply at bedtime to clean, makeup-free skin using a sterile applicator. |
| Dosing/Settings | One sterile applicator per eye, applied along the upper eyelid margin. Do not apply to the lower lash line. |
| Test Spot Requirement | Not required, but monitor for irritation or sensitivity in the first few weeks of use. |
| Pre-Treatment Guidelines | Ensure patient understands proper application technique, potential side effects, and adherence to sterile practices. |
| Provider Clearance Guidelines | NP, PA, MD, or DO must approve; assess eye health history and screen for contraindications. |
| Pre-Treatment Screening Workflow | 1. Confirm patient has no history of glaucoma or severe ocular conditions. 2. Assess for allergies. 3. Educate on potential iris pigmentation changes. |
| What To Do If Adverse Reaction Occurs | For mild irritation: reduce frequency of application. For severe reactions (e.g., vision changes, swelling, allergic reaction): discontinue use and refer to an ophthalmologist. |
| Clinic Implementation Guidelines | Provide patient education on sterile application techniques and storage recommendations. |
| Photographic Documentation Protocol | Optional: baseline and follow-up photos every 4-8 weeks to track progress. |
| Post-Treatment Care | Continue use for optimal results; discontinuation may result in gradual eyelash regression to baseline. |
| Additional Documentation Requirements | Signed informed consent, patient education on proper application and potential side effects, progress tracking notes if applicable. |